BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7572427)

  • 1. The 1990 meningococcal meningitis epidemic of Sarh (Chad): how useful was an earlier mass vaccination?
    Lengeler C; Kessler W; Daugla D
    Acta Trop; 1995 Jun; 59(3):211-22. PubMed ID: 7572427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
    Daugla DM; Gami JP; Gamougam K; Naibei N; Mbainadji L; Narbé M; Toralta J; Kodbesse B; Ngadoua C; Coldiron ME; Fermon F; Page AL; Djingarey MH; Hugonnet S; Harrison OB; Rebbetts LS; Tekletsion Y; Watkins ER; Hill D; Caugant DA; Chandramohan D; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Trotter C; Stuart JM; Maiden M; Greenwood BM
    Lancet; 2014 Jan; 383(9911):40-47. PubMed ID: 24035220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988].
    Spiegel A; Greindl Y; Lippeveld T; Decam C; Granga D; Nahor N; Bordonado JL; Sperber G; Yankalbe M; Baudon D
    Bull World Health Organ; 1993; 71(3-4):311-5. PubMed ID: 8324849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.
    Gamougam K; Daugla DM; Toralta J; Ngadoua C; Fermon F; Page AL; Djingarey MH; Caugant DA; Manigart O; Trotter CL; Stuart JM; Greenwood BM
    Emerg Infect Dis; 2015 Jan; 21(1):115-8. PubMed ID: 25536336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four years of case-based surveillance of meningitis following the introduction of MenAfriVac in Moissala, Chad: lessons learned.
    Page AL; Coldiron ME; Gamougam K; Acyl MA; Tamadji M; Lastrucci C; Hurtado N; Tehoua FC; Fermon F; Caugant DA; Porten K
    Trop Med Int Health; 2017 Dec; 22(12):1561-1568. PubMed ID: 28992391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
    Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
    J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of epidemic group A meningococcal meningitis in Nepal.
    Cochi SL; Markowitz LE; Joshi DD; Owens RC; Stenhouse DH; Regmi DN; Shrestha RP; Lacharya I; Manandhar M; Gurubacharya VL
    Int J Epidemiol; 1987 Mar; 16(1):91-7. PubMed ID: 3570627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal.
    Chippaux JP; Diallo A; Marra A; Etard JF
    Vaccine; 2007 Feb; 25(10):1712-8. PubMed ID: 17240492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemic meningococcal meningitis in central Australia, 1987-1991.
    Patel MS; Merianos A; Hanna JN; Vartto K; Tait P; Morey F; Jayathissa S
    Med J Aust; 1993 Mar; 158(5):336-40. PubMed ID: 7605395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of an epidemic of meningococcal meningitis in Central Africa].
    Merlin M; Martet G; Debonne JM; Nicolas P; Bailly C; Yazipo D; Bougère J; Todesco A; Laroche R
    Sante; 1996; 6(2):87-95. PubMed ID: 8705135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
    Levy C; Taha MK; Bingen E; Cohen R;
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017.
    Hassan A; Mustapha GU; Lawal BB; Na'uzo AM; Ismail R; Womi-Eteng Oboma E; Oyebanji O; Agenyi J; Thomas C; Balogun MS; Dalhat MM; Nguku P; Ihekweazu C
    PLoS One; 2018; 13(6):e0199257. PubMed ID: 29920549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil.
    Cardoso CW; Pinto LL; Reis MG; Flannery B; Reis JN
    Vaccine; 2012 Aug; 30(37):5541-6. PubMed ID: 22749604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningitis in Chad, Niger and Nigeria: 2009 epidemic season.
    Wkly Epidemiol Rec; 2010 Feb; 85(8):47-63. PubMed ID: 20210043
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination.
    Archer BN; Chiu CK; Jayasinghe SH; Richmond PC; McVernon J; Lahra MM; Andrews RM; McIntyre PB;
    Med J Aust; 2017 Nov; 207(9):382-387. PubMed ID: 29092704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Pezzotti P; Miglietta A; Neri A; Fazio C; Vacca P; Voller F; Rezza G; Stefanelli P
    Vaccine; 2018 Jul; 36(29):4222-4227. PubMed ID: 29895504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.